New combo attack on spreading prostate cancer shows promise
NCT ID NCT04748042
Summary
This study is testing a combination treatment for men whose prostate cancer has spread to only a few other places in the body. Doctors are using targeted radiation on the cancer spots along with a short, intense course of hormone therapy and a targeted drug. The main goal is to see if this approach can keep the cancer from getting worse for at least two years without needing continuous hormone therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.